ES2029842T3 - Procedimiento para preparar un derivado de quinolina. - Google Patents

Procedimiento para preparar un derivado de quinolina.

Info

Publication number
ES2029842T3
ES2029842T3 ES198787311275T ES87311275T ES2029842T3 ES 2029842 T3 ES2029842 T3 ES 2029842T3 ES 198787311275 T ES198787311275 T ES 198787311275T ES 87311275 T ES87311275 T ES 87311275T ES 2029842 T3 ES2029842 T3 ES 2029842T3
Authority
ES
Spain
Prior art keywords
prepare
procedure
quinoline derivative
quinoline
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787311275T
Other languages
English (en)
Inventor
Arthur Page Phillips
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of ES2029842T3 publication Critical patent/ES2029842T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Secondary Cells (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Quinoline Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

LA PRESENTE INVENCION TRATA DEL COMPUESTO DE FORMULA (I) Y SUS SALES.
ES198787311275T 1986-12-23 1987-12-22 Procedimiento para preparar un derivado de quinolina. Expired - Lifetime ES2029842T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868630702A GB8630702D0 (en) 1986-12-23 1986-12-23 Quinoline compound

Publications (1)

Publication Number Publication Date
ES2029842T3 true ES2029842T3 (es) 1992-10-01

Family

ID=10609475

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787311275T Expired - Lifetime ES2029842T3 (es) 1986-12-23 1987-12-22 Procedimiento para preparar un derivado de quinolina.

Country Status (22)

Country Link
US (1) US4937248A (es)
EP (1) EP0272910B1 (es)
JP (1) JPS63166866A (es)
KR (1) KR880007514A (es)
AT (1) ATE65993T1 (es)
AU (1) AU594220B2 (es)
CA (1) CA1318671C (es)
DE (1) DE3772015D1 (es)
DK (1) DK163429C (es)
ES (1) ES2029842T3 (es)
FI (1) FI90768C (es)
GB (1) GB8630702D0 (es)
GR (1) GR3002445T3 (es)
HU (1) HU196991B (es)
IE (1) IE60619B1 (es)
IL (1) IL84917A (es)
MX (1) MX9203788A (es)
MY (1) MY102277A (es)
NZ (1) NZ223036A (es)
PH (1) PH23448A (es)
PT (1) PT86448B (es)
ZA (1) ZA879615B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166160A (en) * 1986-12-23 1992-11-24 Burroughs Wellcome Co. Quinoline compound
GB8820174D0 (en) * 1988-08-25 1988-09-28 Wellcome Found Quinoline compound
JP2003525838A (ja) * 1997-09-24 2003-09-02 オリオン コーポレーション ホスホランバン阻害剤としての１−オキサ、アザおよびチアナフタレン−２−オンのビスエーテル類
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
CZ2002711A3 (cs) 1999-08-27 2003-11-12 Ligand Pharmaceuticals Incorporated Modulátory androgenních receptorů, způsoby jejich výroby a způsoby jejich použití
AU6941200A (en) 1999-08-27 2001-03-26 Ligand Pharmaceuticals Incorporated 8-substituted-6-trifluoromethyl-9-pyrido(3,2-g)quinoline compounds as androgen receptor modulators
WO2001019770A2 (en) 1999-09-14 2001-03-22 Ligand Pharmaceuticals Incorporated Rxr modulators with improved pharmacologic profile
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
EP1656142A4 (en) 2003-08-22 2011-06-22 Ligand Pharm Inc 6-CYCLOAMINO-2-QUINOLINONE DERIVATIVES AS MODULATORS ANDROGEN RECEPTOR COMPOUNDS
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
CA3089569C (en) 2007-06-04 2023-12-05 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN108676076A (zh) 2011-03-01 2018-10-19 辛纳吉制药公司 制备鸟苷酸环化酶c激动剂的方法
JP6499591B2 (ja) 2013-02-25 2019-04-10 シナジー ファーマシューティカルズ インコーポレイテッド 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
RS65632B1 (sr) 2013-06-05 2024-07-31 Bausch Health Ireland Ltd Ultra-prečišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i upotrebe
WO2015021358A2 (en) 2013-08-09 2015-02-12 Dominique Charmot Compounds and methods for inhibiting phosphate transport
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス， インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2616855A (en) * 1948-01-15 1952-11-04 Procter & Gamble Detergent composition
US4329347A (en) * 1978-02-17 1982-05-11 Boehringer Ingelheim Gmbh Cardiotonic and antithrombotic sulfur-containing derivatives of carbostyril
JPS5777676A (en) * 1980-10-31 1982-05-15 Otsuka Pharmaceut Co Ltd Carbostyril derivative
PT79699B (en) * 1983-12-22 1986-12-10 Pfizer Process for preparing quinolone inotropic agents
CA1292234C (en) * 1984-05-29 1991-11-19 Simon Fraser Campbell Heterocyclic-substituted quinolone inotropic agents
US4760064A (en) * 1984-12-18 1988-07-26 Otsuka Pharmaceutical Co., Ltd. Carbostyril compounds, compositions containing same and processes for preparing same
US4845100A (en) * 1985-04-12 1989-07-04 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof, processes for preparing the same and cardiotonic composition containing the same
FR2580646A1 (fr) * 1985-04-19 1986-10-24 Synthelabo Derives de 2(1h)-quinolinone, leur preparation et leur application en therapeutique
GB8529362D0 (en) * 1985-11-28 1986-01-02 Pfizer Ltd Quinolone cardiac stimulants
DK111387A (da) * 1986-03-05 1987-09-06 Otsuka Pharma Co Ltd Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
ES2053480T3 (es) * 1986-07-31 1994-08-01 Otsuka Pharma Co Ltd Un procedimiento para preparar un derivado de carboestirilo.

Also Published As

Publication number Publication date
HUT45984A (en) 1988-09-28
FI875666A (fi) 1988-06-24
NZ223036A (en) 1990-11-27
KR880007514A (ko) 1988-08-27
PT86448A (en) 1988-01-01
IL84917A (en) 1991-08-16
EP0272910A1 (en) 1988-06-29
DK163429C (da) 1992-07-20
JPS63166866A (ja) 1988-07-11
DE3772015D1 (de) 1991-09-12
ATE65993T1 (de) 1991-08-15
AU8293387A (en) 1988-06-23
CA1318671C (en) 1993-06-01
FI90768C (fi) 1994-03-25
ZA879615B (en) 1989-08-30
IE873490L (en) 1988-06-23
FI875666A0 (fi) 1987-12-22
IE60619B1 (en) 1994-07-27
GR3002445T3 (en) 1992-12-30
MY102277A (en) 1992-05-15
US4937248A (en) 1990-06-26
FI90768B (fi) 1993-12-15
GB8630702D0 (en) 1987-02-04
MX9203788A (es) 1992-07-01
EP0272910B1 (en) 1991-08-07
HU196991B (en) 1989-02-28
DK680887A (da) 1988-06-24
PH23448A (en) 1989-08-07
AU594220B2 (en) 1990-03-01
IL84917A0 (en) 1988-06-30
PT86448B (pt) 1990-11-20
DK163429B (da) 1992-03-02
DK680887D0 (da) 1987-12-22

Similar Documents

Publication Publication Date Title
ES2029842T3 (es) Procedimiento para preparar un derivado de quinolina.
FR2416222A1 (fr) Derives perfluoroalkyl-thioethyl-ether
MX9203338A (es) Nuevos derivados del oxico a_nor-esteroide-3-carboxilico.
ES2029786T3 (es) Procedimiento para preparar nuevos derivados de quinolina.
FR2453145A1 (es)
FR2383929A1 (fr) 1-hydroxy 2, 3, 4, 5-tetrahydro-1h-3-benzazepines substituees
FR2375218A1 (fr) 2-imidazoline-5-ones a substitution chirale
FR2362170A1 (fr) Nouvelles polyurees
FR2389605A1 (es)
ATE46501T1 (de) Abkoemmlinge der guanidinomethylbenzoesaeure.
FR2383185A1 (es)
ES2032752T3 (es) Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina.
FR2392959A1 (fr) Amino-acides et procede d'obtention
FR2372165A1 (es)
FR2355822A1 (fr) Derives d'esters de l'acide indolacetique. utiles comme anti-inflammatoires et analgesiques
FR2394514A1 (fr) Nouvel acide cyclohexanecarboxylique et ses derives
FR2361351A1 (fr) Intermediaires de preparation d'homologues de somatostatine
FR2389608A1 (es)
FR2359832A1 (fr) 1,3,5-tris-(2-chloroformyl-oxyethyl)-isocyanurate
FR2367761A1 (fr) Derives piperidylideniques de benzo-xanthenes,
FR2446284A1 (fr) Tetrahydro-benzo(c)quinoleine-9(8h)ones
DE3677465D1 (de) N-glykolylneuraminsaeurederivat.
FR2398752A1 (fr) Esters tetracarboxyliques de 2,2,6,6-tetramethyl-piperidino-spiro-dioxanol
FR2443460A1 (fr) Derives mercaptoacyles d'acides 4,5-dihydro-1h-pyrrole-2-carboxyliques et d'acides 1,4,5,6-tetrahydropyridine-2-carboxyliques, utiles comme agents hypotenseurs
ES2062435T3 (es) Nuevas 2-amino-5-ariloximetil-oxazolinas y sus sales.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 272910

Country of ref document: ES